| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.846 | 19.646 | 16.469 | 17.520 | 17.046 | 18.885 | 16.212 | 8.816 | 9.936 | 8.695 |
| Total Income - EUR | 19.846 | 19.647 | 16.470 | 17.521 | 17.047 | 18.887 | 16.213 | 8.816 | 9.937 | 8.698 |
| Total Expenses - EUR | 3.811 | 5.408 | 5.755 | 6.581 | 7.680 | 3.956 | 2.957 | 3.037 | 3.637 | 3.985 |
| Gross Profit/Loss - EUR | 16.034 | 14.238 | 10.715 | 10.940 | 9.366 | 14.931 | 13.255 | 5.779 | 6.299 | 4.713 |
| Net Profit/Loss - EUR | 15.439 | 13.649 | 10.221 | 10.414 | 8.855 | 14.400 | 12.827 | 5.520 | 5.265 | 3.929 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Alfamedmun S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 112 | 320 | 109 | 183 | 116 | 103 | 101 | 101 | 101 | 101 |
| Current Assets | 47.082 | 22.662 | 16.284 | 21.145 | 24.993 | 21.124 | 33.435 | 11.870 | 11.956 | 10.012 |
| Inventories | 565 | 604 | 593 | 599 | 587 | 583 | 681 | 703 | 111 | 0 |
| Receivables | 12.532 | 12.490 | 11.903 | 12.175 | 11.910 | 1.360 | 2.138 | 2.401 | 2.829 | 2.933 |
| Cash | 33.986 | 9.568 | 3.788 | 8.371 | 12.495 | 19.182 | 30.615 | 8.767 | 9.015 | 7.079 |
| Shareholders Funds | 46.504 | 22.180 | 10.572 | 20.793 | 24.187 | 20.556 | 32.927 | 11.377 | 10.947 | 9.352 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 690 | 802 | 5.821 | 535 | 921 | 672 | 609 | 595 | 1.110 | 761 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alfamedmun S.r.l.